Results 21 to 30 of about 918,306 (202)

Renal Sympathetic Denervation: MDCT Evaluation of the Renal Arteries

American Journal of Roentgenology, 2013
Percutaneous transluminal renal sympathetic denervation is a new treatment of refractory systemic hypertension. The purpose of this study was to assess the clinical utility of MDCT to evaluate the anatomic configuration of the renal arteries in the context of renal sympathetic denervation.Two readers retrospectively evaluated the MDCT renal artery ...
Hutchinson, Barry D, Keane, David, Dodd, Jonathan D   +2 more
openaire   +4 more sources

The onset of hypertension in metabolic syndrome is independent of renal sympathetic innervation

Life Science Alliance
In a male rat model of metabolic syndrome, renal denervation before the high-fat diet has only a transient effect, suggesting that hypercaloric diet–induced endocrine changes trigger hypertension independently of renal sympathetic activity.
Omar Flores-Sandoval, Skarleth Cárdenas-Romero, Adrián Báez-Ruiz, Roberto C Salgado-Delgado, Nadia Saderi   +4 more
doaj   +2 more sources

Renal denervation in a patient with Alport syndrome and rejected renal allograft

Indian Heart Journal, 2015
Renal denervation is a new intervention to treat resistant hypertension. By applying radiofrequency (RF) to renal arteries, sympathetic nerves in adventitia layer of vascular wall can be denervated.
Narayana Raju, Vincent Lloyd, Sachin Yalagudri, Bharati Das, A.G. Ravikishore   +4 more
doaj   +2 more sources

Renal sympathetic denervation for treatment of resistant hypertension – Indigenous technique

Indian Heart Journal, 2013
Background: The endovascular approach of ablation of renal sympathetic nerves is found to be effective in the treatment of uncontrolled hypertension.
Gajendra Manakshe, R. Chakravarthi, Shaista Hussaini, Rajeev Menon, A. Srinivas Kumar, V. Ravi Kiran, Gomathi Sundar, C. Narasimhan   +7 more
doaj   +2 more sources

Renal denervation: time to open Pandora’s box

Swiss Medical Weekly, 2012
Depending on the populations studied and the definitions applied, the prevalence of treatment-resistant hypertension varies from 10% to 15%, but is higher in conditions associated with increased sympathetic drive, such as obesity, obstructive sleep
Yu-Mei Gu, Kei Asayama, Yan-Ping Liu, Jan A Staessen   +3 more
doaj   +2 more sources

Future of Renal Sympathetic Denervation in the Treatment of Hypertension

Journal of the American College of Cardiology, 2019
In this issue of the Journal, Sardar et al. (1) report the results of a meta-analysis evaluating the blood pressure (BP) response to renal sympathetic denervation (RSD) in 6 sham-controlled randomized clinical trials including 3 recently published trials and totaling 977 patients.
Kjeldsen, Sverre E., Fadl Elmula, Fadl E.M., Persu, Alexandre   +2 more
openaire   +3 more sources

Quality of life following renal sympathetic denervation in treatment-resistant hypertensive patients: a two-year follow-up study [PDF]

, 2022
Objective. Hypertension is a significant health burden. In the last 10 years, renal sympathetic denervation has been tested as a potential treatment option for a select group of patients with treatmentresistant hypertension.
Hanssen, Tove Aminda, Solbu, Marit Dahl, Subbotina, Anna, Steigen, Terje, Miroslawska, Atena, Anna Subbotina, Tove Aminda Hanssen, Atena Miroslawska, Marit Dahl Solbu, Terje Kristian Steigen   +9 more
core   +1 more source

Renal Sympathetic Denervation: Renal Function Concerns [PDF]

Hypertension, 2011
To the Editor: We have read the report of the Simplicity HTN-1 investigators on the 2-year durability of blood pressure reduction induced by catheter-based renal sympathetic denervation with great excitement1 because it represents a promising approach for treatment of resistant hypertension.2 However, several concerns arise that require clarification.
Petidis, Konstantinos, Anyfanti, Panagiota, Doumas, Michail   +2 more
openaire   +3 more sources

Renal sympathetic denervation in patients with vasospastic angina. [PDF]

J Nucl Cardiol, 2020
Sympathetic overactivity has been linked to vasospastic angina (VSA), although the exact pathophysiology of VSA is poorly understood. The purpose of this study is to assess if renal sympathetic denervation (RDN) reduces cardiac sympathetic nerve activity with a subsequent beneficial effect on angina relief in patients with refractory VSA.Cardiac ...
Feyz L, Henneman M, Verzijlbergen F, Kardys I, Van Mieghem NM, Daemen J.   +5 more
europepmc   +7 more sources

Joint UK societies' 2014 consensus statement on renal denervation for resistant hypertension. [PDF]

, 2014
Resistant hypertension continues to pose a major challenge to clinicians worldwide and has serious implications for patients who are at increased risk of cardiovascular morbidity and mortality with this diagnosis.
Matson, M, Williams, B, Paton, JF, Kapil, Vikas, Moss, J, Simpson, Iain, Knight, Charles, Poulter, Neil, Poulter, N, Collier, David, de Belder, Mark A, Caulfield, Mark J, Matson, Matthew, Simpson, I, Cleveland, Trevor, Deanfield, John, Lobo, MD, de Belder, MA, Williams, Bryan, Lobo, Melvin D, Moss, Jonathan, Caulfield, MJ, Kapil, V, Knight, C, Paton, Julian F R, Dasgupta, I, Paton, JFR, Deanfield, J, ?, ?, Cleveland, T, Collier, D, Dasgupta, Indranil   +31 more
core   +1 more source